Regulatory T cell therapy promotes TGF-β and IL-6-dependent pro-inflammatory Th17 cell generation by reducing IL-2

Journal:

Nature Communications

Published:

2025-08-16

DOI:

10.1038/s41467-025-62628-7

Affiliations:

9

Authors:

19

Go to article

Institutions	Authors	Share
Cancer Center, WCSM/WCH SCH, China	11.000000 11.000000	0.58
State Key Laboratory of Oral Diseases, SCU, China	2.000000	0.11
NIH National Institute of Dental and Craniofacial Research (NIDCR), United States of America (USA)	2.000000	0.11
Chiba University, Japan	1.000000	0.05
MOE Key Laboratory of Birth Defects and Related Disease of Women and Children, SCU, China	1.000000	0.05
Cancer Institute and Hospital, CAMS & PUMC, China	1.000000	0.05
The First Affiliated Hospital, Zhejiang University School of Medicine, China	1.000000	0.05

Interested in Immunology?